Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis
Journal of Extracellular Vesicles · 2026-04 · 15 (4)
DOI: 10.1002/jev2.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 26.03.2026. Verfasst von Ismail Cem Yilmaz und 24 weiteren Autor:innen. Beteiligte Einrichtung: DEU Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Izmir, Türkiye. Hauptthemen laut MEDLINE: Extracellular Vesicles, Leishmaniasis, Leishmaniasis Vaccines, Leishmania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TUBITAK, Scientific and Technological Research Council of Türkiye.
Abstract (Originalsprache)
Leishmaniasis, caused by Leishmania spp., is one of the most neglected tropical diseases and poses a serious threat to public health, accounting for at least one million new cases each year. There is no available human vaccine. In this study, we explored the potential of Leishmania extracellular vesicles (EVs) as a vaccine platform, employing a production and purification method to aid clinical translation and facilitate vaccine development in an affordable setting. Immunization with Leishmania major and Leishmania infantum EVs elicited robust humoral and cellular immune responses, providing protection and cross‐protection against live parasite challenge in selected susceptible BALB/c mouse infection models. Inclusion of specific adjuvants significantly influenced vaccination outcome, highlighting the importance of adjuvant choice in determining effective protection versus susceptibility. Our findings demonstrate the potential of EVs not only for the prevention of leishmaniasis but also for broader applications in combating other protozoan infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DEU Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Izmir, Türkiye.
- Department of Biological Sciences, Middle East Technical University, Ankara, Türkiye.
- Department of Chemistry, Hacettepe University, Ankara, Türkiye.
- Molecular Biology and Genetics Department, Bilkent University, Ankara, Türkiye.
- Institute of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul, Türkiye.
- School of Medicine, Department of Parasitology, Celal Bayar University, Manisa, Türkiye.
ORCID-Profile: Ihsan Gursel, Mayda Gursel
Förderung
- TUBITAK
- Scientific and Technological Research Council of Türkiye
Zitieren
APA
Yilmaz, I. C., Tokmak, I., Yildirim, M., Yildirim, T. C., Ozkoc, E. S., Evcili, I., Ipekoglu, E. M., Ayanoglu, İ. C., Dunuroglu, E., Caliskan, D., Onler, H., Arzum, Z., Ulker, C., Mert, O., Orkut, R., Tarman, I. O., Guler, U., Salih, B., Yazar, V., …, & Gursel, M. (2026). Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis. Journal of Extracellular Vesicles, 15(4). https://doi.org/10.1002/jev2.70252
Vancouver
Yilmaz IC, Tokmak I, Yildirim M, Yildirim TC, Ozkoc ES, Evcili I, et al. Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis. Journal of Extracellular Vesicles. 2026;15(4). doi:10.1002/jev2.70252
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Ismail Cem and Tokmak, Ibrahim and Yildirim, Muzaffer and Yildirim, Tugce Canavar and Ozkoc, Elif Sena and Evcili, Irem and Ipekoglu, Emre Mert and Ayanoglu, İhsan Cihan and Dunuroglu, Emre and Caliskan, Dicle and Onler, Harun and Arzum, Zeynep and Ulker, Ceren and Mert, Olcay and Orkut, Ridvan and Tarman, Ibrahim Oguzhan and Guler, Ulku and Salih, Bekir and Yazar, Volkan and Ozgun, Gokcen and Birincioglu, Serap and Ozbilgin, Ahmet and Gungor, Bilgi and Gursel, Ihsan and Gursel, Mayda},
title = {Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/jev2.70252}
}
EUVIMED